Curis | CRIS - Actif À Court Terme





Actif À Court Terme Changement Date
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 35.3B 2.39B 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
CSL USD 11.85B 1000K 2025-12
Curis USD 6.92M 7.5M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.56B 202M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Merck USD 35.02B 8.5B 2026-03
Novartis USD 27.35B 744M 2026-06
Pfizer USD 42.82B 76M 2026-03
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Takeda JPY 3.15T 59.77B 2026-06
TG Therapeutics USD 1.09B 456.2M 2026-03
Verastem USD 223.41M 69.36M 2025-12